IL-13 is a susceptibility factor for Leishmania major infection

Journal of Immunology

Volumn 164, Issue 3, 2000, Pages 1458-1462

  Matthews, David J ^a   Emson, Claire L ^a   McKenzie, Grahame J ^a   Jolin, Helen E ^a   Blackwell, Jenefer M ^b   McKenzie, Andrew N J ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; HEALING; IMMUNE RESPONSE; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; TRANSGENE;

EID: 0034141850     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.3.1458     Document Type: Article

References (30)

1. Reiner, S., and R. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
2. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of leishmaniasis with anti-interleukin 4 monoclonal antibody. J. Exp. Med. 171:115.
3. Leal, L., D. Moss, R. Kuhn, W. Muller, and F. Liew. 1993. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 23:566.
4. Noben-Trauth, N., P. Kropf, and I. Muller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271:987.
5. Kopf, M., F. Brombacher, G. Kohler, G. Kienzle, K.-H. Widmann, K. Lefrang, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4-deficient BALB/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127.
6. Mohrs, M., B. Ledermann, G. Kohler, A. Dorfmuller, A. Gessner, and F. Brombacher. 1999. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J. Immunol. 162:7302.
7. Noben-Trauth, N., W. E. Paul, and D. L. Sacks. 1999. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 162:6132.
8. Dent, A. L., T. M. Doherty, W. E. Paul, A. Sher, and L. M. Staudt. 1999. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major. J. Immunol. 163:2098.
9. Roberts, M., B. A. Mock, and J. M. Blackwell. 1993. Mapping of genes controlling Leishmania major in CXS recombinant inbred mice. Eur. J. Immunogenet. 20:349.
10. Blackwell, J. M. 1996. Genetic susceptibility to Leishmania infections: studies in mice and men. Parasitology 112:S67.
11. Beebe, A. M., S. Mauze, N. J. Schork, and R. L. Coffman. 1997. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6:551.
12. Zurawski, S., P. Chomarat, O. Djossou, C. Bidaud, A. Mckenzie, P. Miossec, J. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270:13869.
13. McKenzie, G. J., C. L. Emson, S. E. Bell, S. Anderson, P. Fallon, G. Zurawski, R. Murray, and A. N. J. McKenzie. 1998. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9:423.
14. McKenzie, G. J., P. G. Fallon, C. L. Emson, R. K. Grencis, and A. N. J. McKenzie. 1999. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J. Exp. Med. 189:1565.
15. Emson, C. L., S. E. Bell, A. Jones, W. Wisden, and A. N. J. McKenzie. 1998. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J. Exp. Med. 188:399.
16. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4-deficient mice. Science 254:707.
17. McKenzie, G., A. Bancroft, R. Grencis, and A. Mckenzie. 1998. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr. Biol. 8:339.
18. Cooper, A. M., H. Rosen, and J. M. Blackwell. 1988. Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle. Immunology 65:511.
19. Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for qualifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545.
20. Belosovic, M., D. Finbloom, P. Van Der Meide, M. Slayter, and C. Nacy. 1989. Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmanai major. J. Immunol. 143:266.
21. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 179:1367.
22. + T cell response. J. Exp. Med. 181:961.
23. + T cells during initiation of infection. J. Exp. Med. 179:447.
24. + T cells. J. Immunol. 154:5071.
25. Scharton-Kersten, T., L. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-2 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320.
26. Mattner, F., J. Magram, J. Ferrante, P. Lanouis, K. Dipadova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking IL-12 are susceptible to infection with Leishmania major and mount a polarised Th2 cell response. Eur. J. Immunol. 26:1553.
27. Heinzel, F., D. Schoenhaut, R. Rerko, L. Rosser, and M. Gately. 1993. Recombinant IL-12 cures mice infected with Leishmania major. J. Med. 177:1505.
28. Sypek, J., C. Chung, S. Mayor, J. Subramanyam, S. Goldman, D. Sieberth, S. Wolf, and R. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
29. Oswald, I., R. Gazzinelli, A. Sher, and S. James. 1992. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J. Immunol. 148:3578.
30. Doherty, M., K. Kastelein, S. Menon, S. Andrade, and R. Coffman. 1993. Modulation of murine macrophage function by IL-13. J. Immunol. 151:7151.